- Home
- ARBB vs BRTX Comparison
ARBB vs BRTX Comparison
Compare ARBB & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBB
- BRTX
- Stock Information
- Founded
- ARBB 1997
- BRTX 1997
- Country
- ARBB Singapore
- BRTX United States
- Employees
- ARBB N/A
- BRTX N/A
- Industry
- ARBB EDP Services
- BRTX Managed Health Care
- Sector
- ARBB Technology
- BRTX Health Care
- Exchange
- ARBB Nasdaq
- BRTX Nasdaq
- Market Cap
- ARBB 11.9M
- BRTX 12.6M
- IPO Year
- ARBB 2023
- BRTX N/A
- Fundamental
- Price
- ARBB $6.96
- BRTX $1.58
- Analyst Decision
- ARBB Strong Buy
- BRTX Strong Buy
- Analyst Count
- ARBB 1
- BRTX 1
- Target Price
- ARBB $20.00
- BRTX $18.00
- AVG Volume (30 Days)
- ARBB 17.5K
- BRTX 248.6K
- Earning Date
- ARBB 06-27-2025
- BRTX 08-12-2025
- Dividend Yield
- ARBB N/A
- BRTX N/A
- EPS Growth
- ARBB N/A
- BRTX N/A
- EPS
- ARBB N/A
- BRTX N/A
- Revenue
- ARBB $24,425,491.00
- BRTX $391,000.00
- Revenue This Year
- ARBB N/A
- BRTX $391.52
- Revenue Next Year
- ARBB N/A
- BRTX $3.50
- P/E Ratio
- ARBB N/A
- BRTX N/A
- Revenue Growth
- ARBB N/A
- BRTX 161.54
- 52 Week Low
- ARBB $3.22
- BRTX $1.21
- 52 Week High
- ARBB $18.60
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- ARBB 43.03
- BRTX 40.46
- Support Level
- ARBB $6.48
- BRTX $1.60
- Resistance Level
- ARBB $7.46
- BRTX $1.79
- Average True Range (ATR)
- ARBB 0.63
- BRTX 0.12
- MACD
- ARBB 0.14
- BRTX -0.02
- Stochastic Oscillator
- ARBB 75.92
- BRTX 0.00
About ARBB ARB IOT Group Limited
ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.